Tretinoin is a first-generation topical retinoid, a metabolite of Vitamin A (retinol). At 0.05% w/w concentration, it is a mid-potency formulation primarily used in dermatology for its comedolytic, anti-inflammatory, and skin-renewal properties. It acts by binding to specific nuclear retinoic acid receptors (RARs), modulating gene expression, normalizing keratinocyte differentiation, and reducing inflammation. In the Indian context, it is a cornerstone treatment for acne vulgaris and is widely used for photoaging and pigmentary disorders.
Adult: Apply a thin film to the affected area once daily, preferably in the evening. Start with alternate-day application for the first 1-2 weeks to assess tolerance.
Note: 1. Wash face with a mild, non-medicated cleanser and pat dry. 2. Wait 20-30 minutes for skin to dry completely. 3. Apply a pea-sized amount for the entire face. 4. Avoid eyes, eyelids, nostrils, mouth, and mucous membranes. 5. Do not apply to broken or eczematous skin. Use a non-comedogenic moisturizer to manage dryness.
Tretinoin is a ligand for specific nuclear retinoic acid receptors (RAR-α, RAR-β, RAR-γ) within keratinocytes and sebocytes. Binding activates these receptors, which function as transcription factors. This modulates the expression of genes involved in cell proliferation, differentiation, and inflammation. The net effect is normalization of follicular keratinization (reducing comedone formation), increased epidermal cell turnover, reduction of cohesiveness between corneocytes, and inhibition of toll-like receptor 2 (TLR-2) mediated inflammatory pathways.
Pregnancy: Category C (US FDA). Contraindicated. Topical tretinoin is not recommended during pregnancy due to theoretical teratogenic risk, although systemic absorption is minimal. A safer alternative should be used.
Driving: No effect.
| Other Topical Retinoids (Adapalene, Isotretinoin gel) | Additive irritation, risk of severe dermatitis. | Major |
| Topical Benzoyl Peroxide | Concurrent application may oxidize and inactivate tretinoin. Use at different times of day (e.g., BP in AM, tretinoin in PM). | Moderate |
| Topical Salicylic Acid, Alpha Hydroxy Acids (Glycolic, Lactic Acid) | Increased risk of irritation and skin barrier disruption. | Moderate |
| Topical Antibiotics (Clindamycin, Erythromycin) | No significant interaction. Often used in combination therapy. | None |
| Photosensitizing Drugs (Thiazides, Tetracyclines, Fluoroquinolones, Phenothiazines) | Increased risk of photosensitivity reactions. | Moderate |
| Warfarin | Theoretical interaction due to Vitamin A derivative; monitor INR if significant systemic absorption occurs (unlikely). | Minor |
Same composition (Tretinoin (0.05% w/w)), different brands: